Another study noted that inducible nitric oxide synthase (iNOS), matrix metalloproteinase-2 (MMP-2), and NF-κB p65 are closely related to AD progression, suggesting that Tanshinone IIA may lower AD risk by inhibiting the transcription and translation of these genes [83]. The gene discussed is NFKB1; the disease is Alzheimer disease.